Treatment for IgA nephropathy with stage 3 or 4 chronic kidney disease: low-dose corticosteroids combined with oral cyclophosphamide-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Treatment for IgA nephropathy with stage 3 or 4 chronic kidney disease: low-dose corticosteroids combined with oral cyclophosphamide

Published:2020-05-23 Issue:6 Volume:33 Page:1241-1250
ISSN:1121-8428
Container-title:Journal of Nephrology
language:en
Short-container-title:J Nephrol

Author:

Ma Feng,Yang Xiaoxia,Zhou Meilan,Bai Ming,Zhao Lijuan,Li Li,Dong Ruijuan,Liu Chunmei,Li Rong,Sun Shiren

Funder

Natural Science Foundation of China

Key research and development plan of Shaanxi province, China

The discipline boosting program of the Xijing Hospital of the Fourth Military Medical University

Publisher

Springer Science and Business Media LLC

Subject

Nephrology

Link

https://link.springer.com/content/pdf/10.1007/s40620-020-00752-x.pdf

Reference29 articles.

1. Suzuki H, Fan R, Zhang Z, Brown R, Hall S, Julian BA, Chatham WW, Suzuki Y, Wyatt RJ, Moldoveanu Z, Lee JY, Robinson J, Tomana M, Tomino Y, Mestecky J, Novak J (2009) Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity. J Clin Investig 119(6):1668–1677. https://doi.org/10.1172/JCI38468

2. Glassock RJ (2009) Analyzing antibody activity in IgA nephropathy. J Clin Investig 119(6):1450–1452. https://doi.org/10.1172/jci39189

3. Kidney Disease: Improving Global Outcomes (KDIGO) Glomerulonephritis Work Group (2012) KDIGO Clinical Practice Guideline for Glomerulonephritis. Kidney Int Suppl 2:139–274

4. Pozzi C, Sarcina C, Ferrario F (2016) Treatment of IgA nephropathy with renal insufficiency. J Nephrol 29(4):551–558. https://doi.org/10.1007/s40620-015-0257-2

5. Pozzi C, Bolasco PG, Fogazzi GB, Andrulli S, Altieri P, Ponticelli C, Locatelli F (1999) Corticosteroids in IgA nephropathy: a randomised controlled trial. Lancet 353(9156):883–887. https://doi.org/10.1016/s0140-6736(98)03563-6

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunosuppressive therapy versus supportive care in IgA nephropathy patients with stage 3 and 4 chronic kidney disease;Medicine;2022-09-09

2. Effect of corticosteroids combined with cyclophosphamide or mycophenolate mofetil therapy for IgA nephropathy with stage 3 or 4 chronic kidney disease: A retrospective cohort study;Frontiers in Pharmacology;2022-08-31

3. Long-term outcomes of IgA nephropathy patients with less than 25% crescents and mild proteinuria;Clinical and Experimental Nephrology;2021-11-01

4. The prognostic effect of immunosuppressive therapy in IgA nephropathy with stage 3 or 4 chronic kidney disease;Renal Failure;2021-08-10

5. Low-Dose Corticosteroid Combined With Mycophenolate Mofetil for IgA Nephropathy With Stage 3 or 4 CKD: A Retrospective Cohort Study;Clinical Therapeutics;2021-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3